Medico Remedies Peer Comparison

NSE: MEDICO | BSE: 540937

₹21.86

₹0.33 (1.53%)

As on 01-Oct-2026IST

Market cap

₹183 Cr

Revenue (TTM)

₹238 Cr

P/E Ratio

13.2

P/B Ratio

2.3

Div. Yield

0 %

Edit

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	183	20,803	20,009	17,636	16,508
Revenue (₹ Cr)	238	1,682	2,287	2,570	3,230
Net Profit (₹ Cr)	13.82	273.51	678.07	735.15	666.92
Net Margin (%)	5.66	16.19	28.10	26.88	20.60
RoE (%)	19.41	11.15	19.73	19.16	18.75
Price to Earnings	13.21	69.97	30.07	23.99	25.64
Price-To-Book	2.34	7.74	5.45	4.00	4.09

Income Statement (₹ Cr)

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Operating Revenue	237.53	1,682.47	2,287.33	2,569.77	3,229.67
Total Income	243.97	1,689.83	2,413.29	2,735.39	3,237.12
Total Expenditure	220.02	1,203.91	1,490.75	1,628.14	2,090.06
EBITDA	17.50	478.55	796.58	941.63	1,139.61
Depreciation	3.05	126.01	78.10	57.58	281.06
EBIT	14.45	352.55	718.48	884.05	858.55
Interest	1.93	52.11	0.88	7.69	190.64
Other Income	6.45	7.37	125.96	165.62	7.45
Exceptional Items	0.00	12.16	0.00	-49.16	-17.24
Profit before Tax	18.97	319.96	843.56	992.82	658.12
Provision for Tax	5.15	46.45	165.49	257.67	-8.80
Profit after Tax	13.82	273.51	678.07	735.15	666.92

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Shareholder's Funds	75.48	2,591.20	3,586.42	4,202.90	3,902.67
Minority Interest	0.00	0.00	-12.71	0.00	-21.81
Non-Current Liabilities	0.29	266.35	28.74	91.50	1,392.75
Current Liabilities	77.64	848.06	385.94	627.48	2,077.10
Total Liabilities	153.40	3,705.61	4,037.51	4,921.88	7,246.72

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Non-Current Assets	23.15	2,525.44	1,291.22	770.28	5,617.77
Current Assets	128.92	1,109.77	2,585.66	3,803.22	1,539.85
Total Assets	153.40	3,705.61	4,037.51	4,921.88	7,246.72
Total Debt*	18.91	657.97	0.57	2.50	2,309.68
Net Current Assets	51.28	261.71	2,199.72	3,175.74	-537.25
Contingent Liabilities	3.36	160.01	17.53	370.49	51.57

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Cash From Operating Activities	5.87	342.18	523.24	967.57	537.99
Cash Flow from Investing Activities	-4.51	-325.92	-582.30	-561.67	-369.46
Cash from Financing Activities	-0.55	13.62	-46.46	-798.31	-313.53
Net Cash Inflow / Outflow	0.81	29.88	-105.52	-392.41	-145.00

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
ROCE (%)	23.28	11.43	24.97	23.39	14.47
ROE (%)	19.41	11.15	19.73	19.16	18.75
ROA (%)	10.11	7.80	18.69	14.95	9.26
EBIT Margin (%)	6.08	20.95	31.41	34.40	26.58
Net Margin (%)	5.66	16.19	28.10	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Revenue Growth (%)	49.96	27.91	15.01	10.69	9.59
EBIT Growth (%)	20.74	58.32	18.45	24.14	16.84
Net Profit Growth (%)	33.73	149.56	19.61	-9.09	62.68
EPS Growth (%)	33.73	-3.57	17.73	14.40	67.41
Book Value Growth (%)	20.82	9.67	26.75	-0.34	36.71

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Price / Earnings	13.21	74.22	30.07	22.86	24.99
Price / Book Value	2.34	7.74	5.45	4.00	4.09
Dividend Yield (%)	0.00	0.06	0.30	1.95	0.00
EV/EBITDA	11.30	44.75	23.86	15.43	16.45
Market Cap (₹ Cr)	270.87	6,819.66	11,439.22	21,592.90	17,980.08

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debt to Equity	0.00	0.07	0.00	0.00	0.24
Short term debt to equity ratio	0.25	0.16	0.00	0.00	0.12
Current Ratio	1.66	1.31	6.70	6.06	0.74
Quick Ratio	1.27	0.88	5.59	5.31	0.53
Interest Coverage	10.82	7.14	959.59	130.11	4.45

	Medico Remedies	Shilpa Medicare	Caplin Point Lab	Pfizer	Eris Lifesciences
Debtors to sales (%)	34.52	30.84	36.10	7.07	21.07
Asset Turnover	1.74	0.48	0.63	0.52	0.45
Receivable days	123.07	113.81	121.68	26.06	63.88
Inventory Days	50.18	84.76	63.83	65.95	43.27
Payable days	120.69	101.94	108.28	81.01	151.85
Cash Conversion Cycle	52.56	96.62	77.23	11.00	-44.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.